tricotilomania; tinea capitis; efluvio telógeno y anageno; alopecia androgénetica; sifilis; lupus eritematoso sistémico; alopecia de tracción; síndrome de. EPIDEMIOLOGÍA Prevalencia Global del % – % Riesgo a lo largo de la vida 2 % Igual distribución por sexo. En hombres –>Asociación. CELULA la celula es la unidad fundamental anatomica y fisiologica de todo ser vivo. PIEL la piel es el organo mas grande del cuerpo humano.

Author: Morr Kagataxe
Country: Peru
Language: English (Spanish)
Genre: Health and Food
Published (Last): 19 January 2004
Pages: 76
PDF File Size: 10.59 Mb
ePub File Size: 19.58 Mb
ISBN: 136-8-44313-243-6
Downloads: 57299
Price: Free* [*Free Regsitration Required]
Uploader: Dushura

Anormalidades da pele; Quimioterapia; Quimioterapia combinada; Membrana mucosa; Pele. Cabelos, sobrancelhas, barba, pelos axilares e pubianos podem ser acometidos. Com ciclos repetidos de tratamento, pode haver alopecia total.

Tricomegalia e anelamento dos cabelos. Chemotherapeutic agents and the skin: J Am Acad Dermatol. Mucocutaneous reactions to chemotherapy.

Efluvio Telógeno

Cutaneous reactionsto chemotherapy drugs: Hypersensitivity reactions from antineoplastic agents. Cutaneous Toxicities of Cancer Therapy. A randomized trial of minoxidil in chemotherapy-induced alopecia. Classification and management of skin, hair, nail and mucosal side-effects of epidermal growth factor receptor EGFR inhibitors. Trichomegaly of the eyelashes following treatment with cetuximab.

Trichomegaly following treatment with eflkvio ZD Piraccini BM, Iorizzo M. Drug reactions affecting the nail unit: Cutaneous reactions to chemotherapy and their management. Am J Clin Dermatol. Expert Opin Drug Saf. Chapman S, Cohen PR. Transverse leukonychia in patients receiving cancer efluvvio.

Hyperpigmentation of nails from doxorubicin. Cyclophosphamide induced nail pigmentation. Cutaneous reactions to chemotherapeutic agents.


Am J Med Sci. Docetaxel chemotherapy induces transverse superficial loss of the nail plate. Onycholysis as a complication of systemic chemotherapy: Neutrophilic eccrine hidradenitis heralding the onset of chronic myelogenous leukaemia. J Eur Acad Dermatol Venereol. Neutrophilic hidradenitis induced by chemotherapy involves eccrine and apocrine glands. A case of infectious eccrine hidradenitis. Infectious eccrine hidradenitis caused efljvio Nocardia.

Neutrophilic eccrine hidradenitis in a healthy patient. Recurrent neutrophilic eccrine hidradenitis. Nonneoplastic disorders of the eccrine glands. Childhood neutrophilic eccrine hidradenitis: Neutrophilic eccrine hidradenitis in two neutropaenic patients.

Erluvio idiopathic neutrophilic eccrine hidradenitis treated with colchicine. Dapsone in prevention of recurrent neutrophilic eccrine hidradenitis. Chemotherapy-induced eccrine squamous syringometaplasia.

A cutaneous sweat gland reaction in the histologic spectrum of ‘chemotherapy-associated eccrine hidradenitis’ and ‘neutrophilic eccrine hidradenitis’. Eccrine squamous syringometaplasia secondary to pegylated liposomal doxorubicin.

Eccrine squamous syringometaplasia and cytomegalovirus infection. Fixed erythrodysaesthesia plaque due to intravenous injection of docetaxel.

Acral erythrodysesthesia syndrome caused by intravenous infusion of docetaxel in breast cancer. Am J Clin Oncol.

Chemotherapy-induced acral erythema in leukemic patients: Serious hand-and-foot syndrome in black patients treated with capecitabine: Eur J Oncol Nurs.

High-dose methotrexate-induced bullous variant of acral amageno. Palmar-plantar erythrodysesthesia secondary to sunitinib treatment resulting in necrotic foot syndrome aggravated by background diabetic vascular disease. Hand-foot syndrome following prolonged infusion of high doses of vinorelbine. Antineoplastic therapyinduced palmar plantar erythrodysesthesia ‘handfoot’ syndrome. Incidence, recognition and management. Wilkes GM, Doyle D.

Clin J Oncol Nurs. Chemotherapy-induced acral erythema and acute graft-versus-host disease after allogeneic bone marrow transplantation. Pustular acral erythema in a patient with acute graft-versus-host disease. A case of docetaxelinduced erythrodysesthesia.


Efficacy of pyridoxine to ameliorate the cutaneous toxicity associated with doxorubicin containing pegylated stealth liposomes: Antineoplastic therapyinduced palmar plantar erythrodysesthesia ‘hand-foot’ syndrome.

Toxic erythema of chemotherapy: EGFR inhibitor-associated acneiform folliculitis: Epidermal growth factor receptor inhibitor-related skin toxicity: Cutaneous side-effects in cancer patients treated with the antiepidermal growth factor receptor antibody C The management of skin reactions in cancer patients anagrno epidermal growth factor receptor targeted therapies. J Dtsch Dermatol Ges.

Tratamiento de la Alopecia areata

Oropharyngeal mucositis in cancer therapy. Review of pathogenesis, diagnosis, and management. Prevention and treatment of chemo- and radiotherapy-induced oral mucositis.

Chemotherapy- and radiotherapy-induced oral mucositis: Updated clinical practice guidelines for the prevention and treatment of mucositis. Interventions for preventing oral mucositis for patients with cancer receiving treatment. Cochrane Database Syst Rev. Several therapies may prevent or reduce the severity of oral mucositis associated with cancer treatment. Blijlevens N, Sonis S.

Palifermin recombinant keratinocyte growth factor Assinale a alternativa incorreta: Assinale a alternativa correta: Assinale a afirmativa correta: All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License. Services on Demand Journal. Rio Branco, 39 How to cite this article.